79. Discovery of Wrightiadione as a Novel Template for the TrkA Kinase Inhibitors
Jeong, Y.; Lim, S. M.; Hong, S.
Bioorg. Med. Chem. Lett. 2015, 25, 5186.
78. Catalyst Controlled Divergent C4/C8-Site Selective C–H Arylation of IsoquinolonesLee, S.; Mah, S.; Hong, S.Org. Lett. 2015, 17, 3864.Highlighted in Organic Chemistry Portal
77. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors
Park, H.; Lee, S.; Hong, S.
Bioorg. Med. Chem. Lett. 2015, 25, 3784.
76. Tandem Dehydrogenation/Oxidation/Oxidative Cyclization Approach to Wrightiadione and Its Derivatives
Jeong, Y.; Moon, Y.; Hong, S.
Org. Lett. 2015, 17, 3252.
75. Rh(III)-Catalyzed 7-Azaindole Synthesis via C−H Activation/Annulative Coupling of Aminopyridines with Alkynes
Kim, Y.; Hong, S.
Chem. Commun. 2015, 51, 11202. (Highlighted in Synfact September 2015)
74. Ru(II)-Catalyzed Site-Selective Hydroxylation of Flavone and Chromone Derivatives: The Importance of the 5-Hydroxyl Motif for the Inhibition of Aurora Kinases
Kim, K.; Choe, H.; Jeong, Y.; Lee, J. H.; Hong, S.
Org. Lett. 2015, 17, 2550.
74. Asymmetric C–H functionalization of cyclopropanes using an isoleucine-NH2 bidentate
directing group
Kim, J.; Sim, M.; Kim, N.; Hong, S.
Chem. Sci. 2015, 6, 3611. (Highlighted in Literature Coverage in Synform: 2015, 10, A136-A139)
72. Rh(III) and Ru(II)-Catalyzed Site-Selective C–H Alkynylation of Quinolones
Kang, D.; Hong, S.
Org. Lett. 2015, 17, 1938.
71. Rh(I)-Catalyzed Site-Selective Decarbonylative Alkenylation and Arylation of Quinolones under Chelation Assistance
Kwon, S.; Kang, D.; Hong, S.
Eur. J. Org. Chem. 2015, 17, 3615. (Highlighted as a Front Cover)
70. Rh(III)-Catalyzed Direct C–H/C–H Cross-Coupling of Quinones with Arenes Assisted by Directing Group: Identification of Carbazole Quinones as GSKb Inhibitors
Moon, Y.; Jeong, Y.; Kook, D.; Hong, S.
Org. Biomol. Chem. 2015, 13, 3918.
